High-level expression and purification of recombinant huGM-CSF (9-127)/IL-6 (29-184) fusion protein in Escherichia coil (Q40416525)

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

20 September 2017

2 references

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

High-level expression and purification of recombinant huGM-CSF (9-127)/IL-6 (29-184) fusion protein in Escherichia coil (English)

1 reference

20 September 2017

Qiang-ming Sun

1

1 reference

20 September 2017

Hong-chao Jiang

2

1 reference

20 September 2017

Wei-ming Xu

3

1 reference

20 September 2017

Xin Liu

4

1 reference

20 September 2017

Chang-bai Dai

5

1 reference

20 September 2017

Mao-sheng Sun

6

1 reference

20 September 2017

publication date

1 August 2005

1 reference

Protein Expression and Purification

20 September 2017

published in

1 reference

20 September 2017

volume

42

1 reference

20 September 2017

issue

2

1 reference

20 September 2017

page(s)

278-285

1 reference

Enhanced hematopoietic activity of a human granulocyte/macrophage colony-stimulating factor-interleukin 3 fusion protein

20 September 2017

cites work

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.PEP.2005.04.007

Production of recombinant human GM‐CSF‐EPO hybrid proteins: in vitro biological characterization

30 December 2023

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.PEP.2005.04.007

Refolding proteins by gel filtration chromatography.

30 December 2023

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.PEP.2005.04.007

Liver regeneration induced by a designer human IL-6/sIL-6R fusion protein reverses severe hepatocellular injury.

30 December 2023

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.PEP.2005.04.007

Modulation by bryostatin 1 of the in vitro radioprotective effects of the GM-CSF/IL-3 fusion protein, PIXY 321, on normal human myeloid progenitors

30 December 2023

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.PEP.2005.04.007

A Phase I Study of Interleukin-6 After Autologous Bone Marrow Transplantation for Patients with Poor Prognosis Hodgkin's Disease

30 December 2023

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.PEP.2005.04.007

Folding topologies of human interleukin-6 and its mutants as studied by NMR spectroscopy.

30 December 2023

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.PEP.2005.04.007

Randomized, double-blind, placebo-controlled trial to evaluate the hematopoietic growth factor PIXY321 after moderate-dose fluorouracil, doxorubicin, and cyclophosphamide in stage II and III breast cancer

30 December 2023

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.PEP.2005.04.007

Interleukin-6 and interleukin-1 enhancement of GM-CSF-dependent proliferation of haematopoietic progenitor cells in myelodysplastic syndromes

30 December 2023

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.PEP.2005.04.007

Granulocyte-macrophage colony-stimulating factor improves immunological parameters in patients with refractory solid tumours receiving second-line chemotherapy: correlation with clinical responses

30 December 2023

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.PEP.2005.04.007

Toxicity and efficacy of escalating dosages of recombinant human interleukin-6 after chemotherapy in patients with breast cancer or non-small-cell lung cancer

30 December 2023

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.PEP.2005.04.007

Mutagenesis of the human interleukin-6 fourth predicted alpha-helix: involvement of the Arg168 in the binding site.

30 December 2023

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.PEP.2005.04.007

Granulocyte-macrophage colony stimulating factor for the treatment of drug induced agranulocytosis

30 December 2023

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.PEP.2005.04.007

Randomized double-blind prospective trial to evaluate the effects of sargramostim versus placebo in a moderate-dose fluorouracil, doxorubicin, and cyclophosphamide adjuvant chemotherapy program for stage II and III breast cancer

30 December 2023

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.PEP.2005.04.007

Three-dimensional structure of recombinant human granulocyte-macrophage colony-stimulating factor

30 December 2023

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.PEP.2005.04.007

Directly linked soluble IL-6 receptor-IL-6 fusion protein induces astrocyte differentiation from neuroepithelial cells via activation of STAT3

30 December 2023

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.PEP.2005.04.007

Enhancement of hematopoietic reconstitution with recombinant cytokines: effect of rhIL-6 in combination with rhGM-CSF and rhIL-3 on unmodified or T cell-depleted bone marrow

30 December 2023

1 reference

https://opencitations.net/index/api/v1/references/10.1016/J.PEP.2005.04.007

10.1016/J.PEP.2005.04.007

30 December 2023

Identifiers

DOI

1 reference

20 September 2017

1 reference